RE:I think Cardiol Therapeutics is heading to $20.00 per shareVery promotional post... but at least Im on your side.
CRDL needs to get into the US biotech investor group. They will recognize this as a company who has vertically integrated its main ingredient. While it gets its drug's approved, it has a retial product..
1 million grams = 100 million in top line revenue that will be in inventory by Q4/19. MSRP is $100/g if you sell BELOW others (Aphria is like $150/gram) ..You cant even get 80% pure CBD on any major Canadian distribution points..
And think about them selling their water soluble products..
If Canapy, Aphria, Novartis, etc etc are smart, they scoop this up before the it gets to $20.